GSK Claims R&D Misconduct In China Has Been Eliminated
GlaxoSmithKline PLC on Tuesday tried to stanch the bleeding in a fast-evolving scandal surrounding its business dealings in China, acknowledging past misdeeds in its research division while claiming to have subsequently...To view the full article, register now.
Already a subscriber? Click here to view full article